At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FOXO FOXO Technologies
Market Closed 02-14 16:00:00 EST
0.2350
+0.0121
+5.43%
盘后0.2300
-0.0050-2.13%
19:59 EST
High0.2500
Low0.2080
Vol2.92M
Open0.2200
D1 Closing0.2229
Amplitude18.84%
Mkt Cap5.54M
Tradable Cap5.03M
Total Shares23.57M
T/O656.36K
T/O Rate13.64%
Tradable Shares21.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
FOXO Technologies Reports Turnaround and Growth Plans
Foxo Technologies Inc. Announces That Stockholders Equity Is Greater Than $4M, Which Is Required to Meet the Continued Listing Requirements of the Nyse American Exchange
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.